Literature DB >> 20505211

Characterization of subretinal fluid leakage in central serous chorioretinopathy.

Anders Pryds1, Birgit Sander, Michael Larsen.   

Abstract

PURPOSE: The purpose of the study was to determine which category of hydrodynamic phenomena the smokestack in central serous chorioretinopathy (CSC) most likely belongs to: leakage by diffusion or bulk flow.
METHODS: Fluorescein angiograms of 13 eyes of 13 patients were reviewed and analyzed quantitatively. Two methods were used to assess the rate of fluid leakage. One was based on observation of the expansion rate of the bubble of stained fluid seen in the earliest phase of the angiogram, and the other one compared the area of the source of the leakage to the remaining area of retinal pigment epithelium (RPE) exposed to subretinal fluid, by using a standard value for RPE fluid resorption capacity per unit surface area and assuming that resorption equals leakage.
RESULTS: The mean rates of leakage were 16.2 μL/mm(2)/h (95% CI, 11.9-22.1) with the expanding-bubble method and 16.1 μL/mm(2)/h (95% CI, 12.0-21.7) with the area-of-resorption method (P = 0.95, linear correlation r = 0.94). The repeatability coefficient for both methods was 36.3%.
CONCLUSIONS: The study demonstrated sufficient overall agreement between the two methods of assessing leakage rates in smokestack CSC, with adequate repeatability. Leakage rates of the RPE lesions in smokestack CSC occurred at rates consistent with bulk fluid flow, rather than secretion and diffusion, indicating that the primary source of leaking fluid was not the RPE, but a segment of underlying choroidal vasculature.

Entities:  

Mesh:

Year:  2010        PMID: 20505211     DOI: 10.1167/iovs.09-4830

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.

Authors:  Min Zhao; Isabelle Célérier; Elodie Bousquet; Jean-Claude Jeanny; Laurent Jonet; Michèle Savoldelli; Olivier Offret; Antoine Curan; Nicolette Farman; Frédéric Jaisser; Francine Behar-Cohen
Journal:  J Clin Invest       Date:  2012-06-11       Impact factor: 14.808

2.  QT interval dispersion in the patients with central serous chorioretinopathy.

Authors:  Necati Dagli; Burak Turgut; Rumeysa Tanyildizi; Sabiha Kobat; Mehmet Ali Kobat; Orhan Dogdu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

3.  Central serous papillopathy by optic nerve head drusen.

Authors:  Ana Marina Suelves; Ester Francés-Muñoz; Roberto Gallego-Pinazo; Diamar Pardo-Lopez; Jose Luis Mullor; Jose Fernando Arevalo; Manuel Díaz-Llopis
Journal:  Clin Ophthalmol       Date:  2010-11-25

4.  Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.

Authors:  Woo Beom Shin; Min Kyo Kim; Christopher Seungkyu Lee; Sung Chul Lee; Hyesun Kim
Journal:  Korean J Ophthalmol       Date:  2015-11-25

5.  ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.

Authors:  Alejandra Daruich; Alexandre Matet; Laetitia Marchionno; Jean-Dominique De Azevedo; Aude Ambresin; Irmela Mantel; Francine Behar-Cohen
Journal:  Retina       Date:  2017-10       Impact factor: 4.256

6.  The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy.

Authors:  Alireza Maleki; Zahra Nezamdust; Amirmasoud Salari; Seyed Sajad Ahmadi; Hamideh Sabbaghi; Omid Bagherzadeh; Alireza Ataollahi; Mehdi Yaseri
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018

7.  Dark-Field Scanning Laser Ophthalmoscopy for Prediction of Central Serous Chorioretinopathy Responsiveness to Laser Therapy.

Authors:  Alexei N Kulikov; Dmitrii S Maltsev; Maria A Burnasheva; Jay Chhablani
Journal:  J Curr Ophthalmol       Date:  2022-01-06

8.  Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy.

Authors:  Carl Schubert; Anders Pryds; Shemin Zeng; Yajing Xie; K Bailey Freund; Richard F Spaide; John C Merriam; Irene Barbazetto; Jason S Slakter; Stanley Chang; Inger C Munch; Arlene V Drack; Jasmine Hernandez; Suzanne Yzer; Joanna E Merriam; Allan Linneberg; Michael Larsen; Lawrence A Yannuzzi; Robert F Mullins; Rando Allikmets
Journal:  Hum Mutat       Date:  2014-07       Impact factor: 4.700

9.  Smokestack leak on indocyanine green angiography in acute central serous chorioretinopathy.

Authors:  Apoorva Ayachit; Vinod Kumar; Nimmy Raj; Guruprasad Ayachit
Journal:  Indian J Ophthalmol       Date:  2018-08       Impact factor: 1.848

Review 10.  Biomarkers for central serous chorioretinopathy.

Authors:  Gideon Nkrumah; Manuel Paez-Escamilla; Sumit Randhir Singh; Mohammed Abdul Rasheed; Dmitri Maltsev; Abhilash Guduru; Jay Chhablani
Journal:  Ther Adv Ophthalmol       Date:  2020-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.